Cargando…

Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy

Single pH-dependent drug delivery systems have been widely used for colon-targeted delivery, but their efficiency is often hampered by the variation in gut pH. To overcome the limitation of single pH-dependent delivery systems, in this study, we developed and evaluated the therapeutic potential of b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naeem, Muhammad, Choi, Moonjeong, Cao, Jiafu, Lee, Yujeong, Ikram, Muhammad, Yoon, Sik, Lee, Jaewon, Moon, Hyung Ryong, Kim, Min-Soo, Jung, Yunjin, Yoo, Jin-Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516197/ https://www.ncbi.nlm.nih.gov/pubmed/26229440 http://dx.doi.org/10.2147/DDDT.S88672

Ejemplares similares

Enhanced therapeutic efficacy of budesonide in experimental colitis with enzyme/pH dual-sensitive polymeric nanoparticles
por: Naeem, Muhammad, et al.
Publicado: (2015)

Colon-targeted delivery of cyclosporine A using dual-functional Eudragit(®) FS30D/PLGA nanoparticles ameliorates murine experimental colitis
por: Naeem, Muhammad, et al.
Publicado: (2018)

Hyaluronic Acid-Conjugated PLGA Nanoparticles Alleviate Ulcerative Colitis via CD44-Mediated Dual Targeting to Inflamed Colitis Tissue and Macrophages
por: Hlaing, Shwe Phyu, et al.
Publicado: (2022)

Nitric oxide-releasing poly(lactic-co-glycolic acid)-polyethylenimine nanoparticles for prolonged nitric oxide release, antibacterial efficacy, and in vivo wound healing activity
por: Nurhasni, Hasan, et al.
Publicado: (2015)

Increased therapeutic efficacy of a newly synthesized tyrosinase inhibitor by solid lipid nanoparticles in the topical treatment of hyperpigmentation
por: Al-Amin, Md, et al.
Publicado: (2016)

Bacteria-Targeted Clindamycin Loaded Polymeric Nanoparticles: Effect of Surface Charge on Nanoparticle Adhesion to MRSA, Antibacterial Activity, and Wound Healing
por: Hasan, Nurhasni, et al.
Publicado: (2019)

Preparation and characterization of pH-sensitive nanoparticles of budesonide for the treatment of ulcerative colitis
por: Zhou, Hong, et al.
Publicado: (2018)

Use of Budesonide in the Treatment of Microscopic Colitis
por: Tangri, Vikram, et al.
Publicado: (2010)

Nintedanib-Induced Colitis Treated Effectively With Budesonide
por: Amini, Afshin, et al.
Publicado: (2020)

pH-Responsive Alginate-Based Microparticles for Colon-Targeted Delivery of Pure Cyclosporine A Crystals to Treat Ulcerative Colitis
por: Oshi, Murtada A., et al.
Publicado: (2021)

Lack of effect of methotrexate in budesonide-refractory collagenous colitis
por: Münch, Andreas, et al.
Publicado: (2013)

Budesonide Multi-matrix for the Treatment of Patients with Ulcerative Colitis
por: Lichtenstein, Gary R.
Publicado: (2015)

Budesonide-Related Iatrogenic Cushing’s Syndrome in Microscopic Colitis
por: Tripathi, Kartikeya, et al.
Publicado: (2017)

Dual pH and microbial-sensitive galactosylated polymeric nanocargoes for multi-level targeting to combat ulcerative colitis
por: Zeeshan, Mahira, et al.
Publicado: (2023)

Long-term safety and efficacy of budesonide in the treatment of ulcerative colitis
por: Iborra, Marisa, et al.
Publicado: (2014)

Budesonide treatment for microscopic colitis from immune checkpoint inhibitors
por: Hughes, Michael S., et al.
Publicado: (2019)

Budesonide MMX in the Treatment of Ulcerative Colitis: Current Perspectives on Efficacy and Safety
por: Maconi, Giovanni, et al.
Publicado: (2021)

Pro-apoptotic effect of the novel benzylidene derivative MHY695 in human colon cancer cells
por: Heo, Gwangbeom, et al.
Publicado: (2019)

Evaluation of glycine-bearing celecoxib derivatives as a colon-specific mutual prodrug acting on nuclear factor-κB, an anti-inflammatory target
por: Lee, Sunyoung, et al.
Publicado: (2015)

Budesonide Foam for Ulcerative Colitis Patients Experiencing Inadequate Response to Biological Therapy
por: Shibuya, Tomoyoshi, et al.
Publicado: (2019)

Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental mice
por: Xian, Shiyun, et al.
Publicado: (2023)

The Effectiveness of Budesonide Nasal Irrigation in Patients with Allergic Rhinitis
por: Ishak, Muhammad Nu’aim, et al.
Publicado: (2022)

Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process
por: Ha, Eun-Sol, et al.
Publicado: (2015)

Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma
por: Morice, A H, et al.
Publicado: (2007)

Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis
por: Lichtenstein, Gary R., et al.
Publicado: (2015)

Budesonide as induction therapy for incomplete microscopic colitis: A randomised, placebo‐controlled multicentre trial
por: Münch, Andreas, et al.
Publicado: (2021)

Lentinan-Based Oral Nanoparticle Loaded Budesonide With Macrophage-Targeting Ability for Treatment of Ulcerative Colitis
por: Lin, Meisi, et al.
Publicado: (2021)

Mucosa associated invariant T and natural killer cells in active and budesonide treated collagenous colitis patients
por: Daferera, Niki, et al.
Publicado: (2022)

PSAT050 An Unusual Case of Adrenal Insufficiency After Using Budesonide for Treatment of Microscopic Colitis
por: Barua, Nabonita, et al.
Publicado: (2022)

A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model
por: Yang, Yejin, et al.
Publicado: (2018)

A Colon-Targeted Prodrug, 4-Phenylbutyric Acid-Glutamic Acid Conjugate, Ameliorates 2,4-Dinitrobenzenesulfonic Acid-Induced Colitis in Rats
por: Kim, Soojin, et al.
Publicado: (2020)

Celecoxib coupled to dextran via a glutamic acid linker yields a polymeric prodrug suitable for colonic delivery
por: Lee, Yonghyun, et al.
Publicado: (2015)

Anti-Inflammatory Effects of the Novel Barbiturate Derivative MHY2699 in an MPTP-Induced Mouse Model of Parkinson’s Disease
por: Lee, Seulah, et al.
Publicado: (2021)

Protocol: Influence of Budesonide and Budesonide/Formoterol on Asthma Control in Smoking Asthmatic Adults
por: Boulet, Louis-Philippe, et al.
Publicado: (2010)

Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
por: Kim, Sei Won, et al.
Publicado: (2016)

Colon Delivery of Budesonide Using Solid Dispersion in Dextran for the Treatment and Secondary Prevention of Ulcerative Colitis in Rat
por: Varshosaz, Jaleh, et al.
Publicado: (2010)

Reduced Intake of Dietary Tryptophan Improves Beneficial Action of Budesonide in Patients with Lymphocytic Colitis and Mood Disorders
por: Chojnacki, Cezary, et al.
Publicado: (2023)

Fabrication and In Vitro Evaluation of pH-Sensitive Polymeric Hydrogels as Controlled Release Carriers
por: Suhail, Muhammad, et al.
Publicado: (2021)

A Case of Esophageal Candidiasis in an Adolescent Who Had Frequently Received Budesonide Nebulizing Therapy
por: Kang, Hae Ryong, et al.
Publicado: (2013)

N-Succinylaspartic-Acid-Conjugated Riluzole Is a Safe and Potent Colon-Targeted Prodrug of Riluzole against DNBS-Induced Rat Colitis
por: Kim, Jaejeong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rfhocqtqasg4oliigsrcr0n1m6